Pathology Lectures

Pneumonia in the Immunocompromised Host

74 slides · PPTX & PDF available

Download PDF
Request PowerPoint

PowerPoint animations are preserved in the original file.

Marks are temporary. Tap a drawing tool again to stop.
Slide index (74)
  1. Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Slide index & full transcript (74 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Pneumonia in the Immunocompromised Host

Pathologic mechanisms, major pathogens, morphology, and diagnostic reasoning

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Recognize the clinical significance of a new infiltrate in an immunocompromised host.

Connect the immune defect with likely infectious agents and tissue responses.

Differentiate characteristic pulmonary patterns and morphologies.

Distinguish opportunistic infection from conventional pneumonia and noninfectious mimics.

Slide 3 · Why pulmonary infiltrates demand attention

New infiltrates are among the common, serious complications of immune suppression.

Fever and other typical signs of infection may be absent.

The differential is broader than in immunocompetent hosts.

Opportunistic infections carry substantial mortality.

Slide 4 · Clinical settings associated with immune suppression

Underlying disease

Immune dysfunction arising from illness, including HIV or hematologic disease.

Therapeutic suppression

Immunosuppressive drugs given after organ or stem-cell transplantation.

Cancer therapy

Cytotoxic chemotherapy or irradiation that impairs host defenses.

Slide 5 · Host defense failure changes the organism spectrum

Airway / alveolar exposure

Inhaled or aspirated microbes

Reduced immune containment

Barrier, phagocyte, or cellular defects

Pulmonary infection

Conventional or opportunistic pathogens

Slide 6 · Three defenses relevant to pulmonary infection

Airway clearance

Limits deposition and persistence of inhaled microbes.

Phagocyte defense

Macrophages and neutrophils contain bacteria and mold spores.

Cell-mediated immunity

T-cell responses limit intracellular pathogens and many opportunists.

Slide 7 · The same infiltrate may have different causes

Infectious

Conventional bacterial pneumonia

Opportunistic fungal disease

Viral infection or reactivation

More than one pathogen

Noninfectious

Drug-related pulmonary injury

Pulmonary involvement by malignancy

Other treatment-associated lung injury

Slide 8 · Opportunistic infection is not synonymous with pneumonia

Many opportunists rarely cause disease in normal hosts.

In a compromised host, these microbes may cause severe pulmonary infection.

However, ordinary respiratory pathogens remain relevant.

An opportunist in a sample must be interpreted in clinical and tissue context.

Slide 9 · Conventional organisms remain important

Gram-positive bacteria

Streptococcus pneumoniae and Staphylococcus aureus.

Respiratory gram-negative bacteria

Haemophilus influenzae and other gram-negative rods.

Hospital-associated organisms

Pseudomonas aeruginosa and resistant bacterial pathogens.

Slide 10 · Distribution helps organize—but not settle—the differential

Distributed abnormalities

Localized abnormalities

A pattern suggests a differential—not a specific diagnosis.

Schematic — not a histologic image

Slide 11 · Pulmonary infiltrates: Common pattern associations

Predominantly diffuse

Predominantly focal

Cytomegalovirus

Gram-negative bacterial infection

Pneumocystis jirovecii

Staphylococcus aureus

Drug reaction

Aspergillus or Candida

Other infectious / neoplastic causes

Malignancy or other focal processes

Patterns overlap; Distribution alone cannot identify the pathogen.

Slide 12 · Co-infection is a defining diagnostic difficulty

More than one microbial cause may coexist in a single patient.

An identified organism need not account for every lung lesion.

Different patterns can reflect simultaneous infection and noninfectious injury.

Interpret microbiologic results alongside distribution and host history.

Slide 13 · A disciplined approach to a new infiltrate

Define the host

Immune defect and exposures

Define the lesion

Diffuse, focal, necrotizing

Define the agent

Microbiology and tissue findings

Reconcile causes

Infection ± noninfection

Slide 14 · Host-response patterns vary with immune competence

Relatively preserved defenses

Neutrophilic exudates can be conspicuous

Granulomas may form against intracellular agents

Tissue reaction may make infection more apparent

Marked immune failure

Organisms can be numerous with little inflammation

Necrosis and vascular invasion can dominate

Granulomatous response may be attenuated

Slide 15 · Why a negative inflammatory response is not reassuring

The immune system generates much of the visible cellular response.

Severe immune defects can reduce the histologic reaction to an organism.

Organism burden and tissue inflammation need not correlate.

Special stains and organism-directed methods remain important.

Slide 16 · HIV changes—but does not replace—the differential

Pulmonary disease is a major cause of hospitalization in HIV infection.

Antiretroviral therapy and chemoprophylaxis have altered outcomes.

Conventional bacterial disease and opportunistic disease both remain relevant.

Noninfectious lesions must also be excluded.

Slide 17 · CD4-positive T-cell depletion changes pathogen probability

Relatively preserved CD4 counts

Usual bacterial pneumonia Tuberculosis

Below 200 cells/mm³

Pneumocystis pneumonia becomes prominent

Below 50 cells/mm³

CMV, MAC, and some fungal infections

These are source-described associations in HIV, not universal diagnostic thresholds.

Slide 18 · At higher CD4 counts, do not overlook common infections

Usual bacterial pneumonia

S. Pneumoniae, S. Aureus, H. Influenzae, gram-negative rods.

Tuberculous disease

May occur with relatively preserved CD4 T-cell numbers.

Clinical significance

Bacterial infection in HIV may be more severe and bacteremic.

Slide 19 · Pneumocystis emerges with advanced cellular immune failure

Pneumocystis pneumonia is particularly associated with CD4 counts below 200 cells/mm³ in HIV infection.

The dominant lesion involves alveolar exudate and interstitial thickening.

Opportunistic pathogens can be missed if only conventional bacteria are considered.

Slide 20 · Very advanced HIV broadens the pathogen spectrum

Cytomegalovirus

Important viral infection/reactivation in marked immunodeficiency.

Mycobacterium avium complex

Intracellular organisms may become abundant within macrophages.

Invasive fungal disease

Risk increases as cellular defenses become profoundly impaired.

Slide 21 · Pulmonary infiltrates in HIV: Infection versus tumor

Infectious examples

Ordinary bacterial pneumonia

Pneumocystis pneumonia

Mycobacterial / fungal disease

CMV and other viral disease

Neoplastic examples

Kaposi sarcoma

Non-Hodgkin lymphoma

Primary lung carcinoma

Slide 22 · Why extensive investigation may be justified in HIV

Atypical presentations can occur even with common pathogens.

Two or more etiologies may coexist.

Opportunistic and noninfectious lesions have overlapping appearances.

Diagnosis requires synthesis rather than a single imaging pattern.

Slide 23 · Bacterial causes emphasized in immunocompromised hosts

Organism

Reason for emphasis

Pseudomonas aeruginosa

Neutropenia, hospital acquisition, vascular invasion

Legionella pneumophila

Transplant / systemic immune compromise

Mycobacterium species

Intracellular survival; Granulomas may fail to form

Listeria monocytogenes

Recognized opportunistic bacterial pathogen

Conventional respiratory bacteria

Remain causes of serious pulmonary infection

Slide 24 · Pseudomonas: Neutropenia and vascular invasion

Reduced neutrophil defense

Impaired early containment

Pseudomonas pneumonia

Serious gram-negative infection

Vascular invasion

Bacteremia and systemic spread

Slide 25 · Legionella in susceptible hosts

Organisms grow in artificial water environments.

Aerosol inhalation or aspiration can introduce infection.

Organ-transplant recipients are particularly susceptible.

Pulmonary infection can be severe; Molecular testing, antigen detection, and culture are diagnostic approaches.

Slide 26 · Nocardia: An additional opportunistic pulmonary differential

Organism

Aerobic, branching, gram-positive bacterium; Not a fungus.

Predisposition

Corticosteroid exposure, HIV infection, or diabetes.

Clinical pattern

Indolent lung infection; May mimic tuberculosis or malignancy and disseminate to CNS.

Slide 27 · Mycobacterium avium complex: A distinctive tissue response

Marked immunodeficiency permits proliferation within macrophages.

Macrophages may contain abundant acid-fast bacilli.

Granulomas, lymphocytes, and tissue destruction can be surprisingly sparse.

Infection may be pulmonary or disseminated through mononuclear phagocyte tissues.

Slide 28 · Why profound immune failure can erase a granulomatous pattern

More effective cellular response

Profound immune failure

Organized macrophage response

Numerous bacilli; Poor granuloma

Schematic — not a histologic image

Slide 29 · Viral pulmonary pathogens in immune compromise

Cytomegalovirus

Latent herpesvirus capable of reactivation when cellular immunity falls.

Herpesviruses

Herpes simplex and varicella-zoster viruses can cause visceral / pulmonary disease.

Interpretation

Specific evidence of tissue infection matters when assessing clinical significance.

Slide 30 · CMV: Latency, reactivation, tissue injury

Latency

Monocytes / marrow progenitors

T-cell immune impairment

Loss of immune restraint

Reactivation

Infection of visceral cells

Tissue injury

Cytomegaly and focal necrosis

Slide 31 · CMV cytopathic change: An inclusion pattern

Enlarged infected cell

Large nuclear inclusion

Clear perinuclear halo

Schematic of cytopathic features — not a photomicrograph

Slide 32 · CMV in lung: Which cells are affected?

Pulmonary epithelial cells can be infected.

Alveolar macrophages and endothelial cells may contain the virus.

Characteristic enlarged cells show intranuclear inclusions with a surrounding halo.

Focal necrosis may accompany a relatively limited inflammatory reaction.

Slide 33 · Varicella-zoster and other herpesvirus pneumonitis

Varicella-zoster virus can produce interstitial pneumonia in immunosuppressed people.

Herpesviruses belong in the viral differential beyond CMV.

A specific viral tissue effect is more informative than a nonspecific infiltrate pattern.

Slide 34 · Pneumocystis jirovecii: Organism and host setting

Organism

Yeast-like fungus with pulmonary tropism.

Predisposition

Impaired cellular immunity; Historically prominent in AIDS.

Pulmonary syndrome

Potentially rapidly progressive bilateral pneumonia.

Slide 35 · Pneumocystis: How alveolar disease develops

Airborne acquisition

Respiratory exposure

Insufficient immune clearance

Organism persistence

Alveolar filling

Foamy eosinophilic material

Gas-exchange impairment

Diffuse pulmonary disease

Slide 36 · Pneumocystis alveolitis: Tissue-level schematic

Foamy eosinophilic intra-alveolar material

Thickened / inflamed septa

Schematic — not a histologic image

Slide 37 · Pneumocystis: What routine tissue morphology shows

Alveolar spaces contain eosinophilic, foamy or honeycomb-like exudate.

Alveolar septa may show interstitial thickening.

Pneumocystis structures can be inconspicuous on routine staining.

The pattern should prompt targeted organism detection.

Slide 38 · Pneumocystis: Organism forms versus stain visibility

Cell-wall forms

Cyst / ascus forms are highlighted by methenamine silver stains.

Cyst appearance may be cup-like or crushed-ball shaped.

Other forms / testing

Trophic forms are not highlighted by a fungal cell-wall silver stain.

Immunofluorescent assays and PCR can identify infection.

Slide 39 · Pneumocystis diagnostic methods: Interpretive roles

Method

Contribution

Limitation

Methenamine silver

Shows cyst / ascus walls

Does not visualize trophic forms well

Immunofluorescence

Identifies organisms

Requires appropriate specimen

PCR

Detects organism nucleic acid

Clinical context still essential

β-D-glucan

Supports fungal infection

Not specific for Pneumocystis

Slide 40 · Pneumocystis outside the lung is uncommon

The primary target is lung parenchyma.

Extrapulmonary infection may involve lymph nodes, spleen, marrow, or liver.

The pulmonary presentation remains central to diagnosis and teaching.

Slide 41 · Aspergillus causes biologically different lung diseases

Allergic response

Airway-associated hypersensitivity in susceptible hosts.

Colonization

Aspergilloma within a previously formed pulmonary cavity.

Invasion

Hyphae invade parenchyma and vessels in immunosuppressed hosts.

Slide 42 · From inhaled Aspergillus conidium to tissue invasion

Inhaled conidia

Reach the alveoli

Macrophage / neutrophil defense

Normally contain conidia and hyphae

Impaired host defense

Hyphal germination and growth

Invasion

Tissue and vascular destruction

Slide 43 · Why neutropenia predicts invasive aspergillosis

Macrophages ingest and kill inhaled conidia.

Neutrophils are crucial for killing hyphal forms.

Corticosteroids or neutropenia weaken fungal containment.

Once germinated, hyphae may breach tissue and blood vessels.

Slide 44 · Septate fungal hyphae with acute-angle branching

Septate hyphae with characteristic acute-angle branching

Schematic — not a histologic image

Slide 45 · Invasive aspergillosis: The major pulmonary lesion

A necrotizing pneumonia may form rounded, sharply delimited lesions.

Hemorrhagic borders result from vascular injury.

Intravascular hyphae can cause thrombosis and infarction.

Hematogenous dissemination may involve brain, eyes, skin, liver, and kidneys.

Slide 46 · Aspergilloma is not invasive aspergillosis

Aspergilloma (colonization)

Hyphal fungus ball occupies an existing cavity.

Minimal tissue invasion is characteristic.

Hemoptysis can occur.

Invasive pulmonary aspergillosis

Invasive hyphae infiltrate parenchyma and vessels.

Necrosis, hemorrhage, and infarction develop.

Occurs with significant immune impairment.

Slide 47 · Angioinvasion explains the hemorrhagic lesion

Hyphae enter vascular wall

Direct tissue invasion

Vascular thrombosis

Reduced local perfusion

Ischemic necrosis

Infarction and tissue loss

Hemorrhage

Vascular wall damage

Slide 48 · Morphology has limits for species identification

Aspergillus often produces septate, acute-angle branching hyphae in tissue.

Fusarium and Scedosporium / Pseudallescheria can appear similar.

Fungal morphology narrows the differential but may not establish species.

Additional microbiologic correlation is required.

Slide 49 · Mucormycosis: Why particular hosts are susceptible

Defective phagocytes

Neutropenia or substantial immunosuppression.

Metabolic vulnerability

Diabetes mellitus, particularly with ketoacidosis.

Other predispositions

Corticosteroids and increased bioavailable iron.

Slide 50 · Hyphal morphology: Aspergillus versus Mucorales

Aspergillus-type

Mucorales-type

Narrow; Frequent septa; Acute angles

Broad, irregular; Few septa; Wider angles

Schematic — not a histologic image

Slide 51 · Pulmonary mucormycosis is a vascular disease

Mucorales can enter the lung after inhalation of airborne spores.

Broad, irregular, sparsely septate hyphae invade tissues.

Invasion of vessel walls creates thrombosis and ischemic necrosis.

Hemorrhagic pneumonia and pulmonary infarctions may coexist.

Slide 52 · Aspergillus and Mucorales: Shared behavior, different hyphae

Aspergillus

Septate hyphae, often acute-angle branching.

Invasive disease: Necrotizing hemorrhagic lung lesions.

Neutropenia and corticosteroids are major risks.

Mucorales

Broader, irregular, pauci-/nonseptate hyphae; Often near-right-angle branches.

Thrombosis and hemorrhagic infarction.

Diabetes / iron and neutrophil defects add susceptibility.

Slide 53 · Candida: Opportunist, tissue forms, and host defenses

Predisposition

Neutropenia, chemotherapy, invasive devices, or severe illness.

Tissue forms

Budding yeasts, pseudohyphae, occasionally true hyphae.

Dissemination

Bloodborne spread can produce microabscesses in distant organs.

Slide 54 · Candida budding yeast and pseudohyphae

Budding yeast

Pseudohyphae: Elongated buds joined at constrictions

Schematic — not a histologic image

Slide 55 · Invasive candidiasis: Context determines significance

Candida may be part of normal human microbiota.

Disease potential increases with immune defects and barrier disruption.

Invasive disease may provoke suppuration, scant reaction, or granulomas.

Finding fungi at a respiratory site requires evidence-based interpretation of invasion.

Slide 56 · Cryptococcus neoformans: Capsule-mediated immune evasion

Route

Usually acquired by inhalation from environmental sources.

Major virulence factor

Thick polysaccharide capsule inhibits phagocytosis and immune recruitment.

Pulmonary role

Lung is a primary portal; Infection may be clinically mild before dissemination.

Slide 57 · Cryptococcus: The capsule is a diagnostic clue

Encapsulated yeast

Broad polysaccharide capsule

Capsular material is highlighted by mucicarmine in tissue.

Schematic — not a histologic image

Slide 58 · Cryptococcal disease links lung and central nervous system

Pulmonary disease can be mild even when extrapulmonary spread occurs.

Encapsulated yeasts are demonstrable in tissue with mucicarmine and other stains.

Severe immunosuppression can permit organism proliferation with little inflammation.

Granulomatous responses may occur when host defenses are relatively preserved.

Slide 59 · Histoplasma: Host response determines morphology

More effective cellular immunity

Granulomatous reaction in the lung.

Lesions may necrose and ultimately fibrose or calcify.

Intracellular small yeasts require identification.

Severe immune deficiency

Disseminated infection with macrophages laden with yeasts.

Granuloma formation may be poor or absent.

Histology differs despite the same organism.

Slide 60 · Morphology-oriented comparison of major pathogens

Agent

Characteristic tissue clue

Key pitfall

Pneumocystis

Foamy alveolar exudate; Silver-positive cysts

Silver stain misses trophic forms

CMV

Enlarged cells; “owl-eye” inclusions

Infiltrate pattern alone nonspecific

Aspergillus

Septate, acute-angle branching hyphae

Other hyaline molds can mimic

Mucorales

Broad, variable, pauci-septate hyphae

Tissue damage may obscure architecture

Cryptococcus

Encapsulated budding yeasts

Weak host response can mask disease

Slide 61 · Immune defect influences pathogen and tissue reaction

Immune defect

Pathogen tendency

Tissue response

T-cell depletion

Pneumocystis / CMV / MAC

Foamy exudate; Inclusions; Macrophage-rich disease

Neutrophil dysfunction

Aspergillus / Mucorales / Pseudomonas

Necrosis, suppuration, or vascular invasion

Variable host reserve

Conventional bacteria and other agents

Response may be attenuated or mixed

Slide 62 · Diagnostic stains and tests: Organism-oriented overview

Suspected agent

Useful evidence from the source

Pneumocystis

Methenamine silver; Immunofluorescence; PCR; β-D-glucan adjunct

CMV

Characteristic cytomegalic inclusions in infected tissue

MAC

Numerous acid-fast bacilli within macrophages

Candida / Aspergillus / Mucorales

Tissue fungal forms; GMS/PAS where appropriate

Cryptococcus

Encapsulated yeast; Mucicarmine and PAS in tissue

Legionella

PCR, urinary antigen, and culture

Slide 63 · Interpretation of a lung specimen in immune compromise

Describe injury

Exudative, interstitial, necrotizing

Look for organisms

H&E and targeted methods

Evaluate invasion

Parenchymal / vascular involvement

Integrate host

Clinical risk, imaging, other tests

Slide 64 · Pulmonary infiltrate: Infection versus noninfectious injury

Evidence supporting infection

Demonstrable organism with relevant lesion

Microbiology compatible with host / pathology

Fungal or viral tissue invasion where applicable

Alternative / coexisting disease

Drug toxicity

Kaposi sarcoma or lymphoma

Other pulmonary neoplasm

Coexisting infectious and noninfectious lesions

Slide 65 · Differential by tissue-response pattern

Observed tissue pattern

Illustrative considerations

Alveolar foamy exudate

Pneumocystis pneumonia

Cytomegalic cells / inclusions

CMV disease

Necrotizing hemorrhagic angioinvasion

Aspergillus or Mucorales

Macrophages packed with AFB

Disseminated / pulmonary MAC

Granulomas with yeasts

Cryptococcus or Histoplasma; Response may be absent in profound immunodeficiency

Suppurative consolidation

Usual bacterial pathogens

Slide 66 · Clinical application: Neutropenia with focal lung lesions

CLINICAL STEM

A patient receiving chemotherapy develops new rounded pulmonary lesions. A biopsy shows necrosis, hemorrhage, and infiltrating fungal hyphae.

Which pathologic mechanism best explains the hemorrhagic lesions?

Slide 67 · Case interpretation: Vascular invasion by mold

The leading mechanism is hyphal penetration of vessel walls.

Thrombosis and ischemic infarction combine with hemorrhagic tissue destruction.

Septation and branching pattern help distinguish Aspergillus from Mucorales, but are not species-definitive.

Slide 68 · Clinical application: Advanced HIV with diffuse disease

CLINICAL STEM

A person with advanced HIV presents with bilateral pulmonary infiltrates. Tissue shows thickened alveolar walls and foamy luminal material.

Which organism and targeted stain or assay should be considered?

Slide 69 · Case interpretation: Pneumocystis alveolitis

Pneumocystis jirovecii produces foamy intra-alveolar material and interstitial inflammation.

Methenamine silver can reveal the cyst / ascus walls.

Immunofluorescence and PCR provide other diagnostic approaches; β-D-glucan is supportive, not specific.

Slide 70 · Clinical application: Transplant recipient with viral injury

CLINICAL STEM

A transplant recipient develops pulmonary infiltrates. Enlarged lung cells contain large intranuclear inclusions surrounded by a clear halo.

Which viral infection is suggested by this cytopathic morphology?

Slide 71 · Case interpretation: Cytomegalic inclusion disease

Cytomegalovirus reactivation is favored in a patient with suppressed cellular immunity.

Cytomegaly and prominent intranuclear inclusions are the tissue clues.

Correlate the inclusions with the clinical syndrome and other infectious possibilities.

Slide 72 · Core clinicopathologic distinctions

Always consider both

Conventional and opportunistic pathogens can coexist.

Read the host

Type and depth of immune defect strongly influence probability.

Read the tissue

Cytopathic effect, foamy exudate, angioinvasion, and intracellular organisms guide the differential.

Slide 73 · Final synthesis

Pulmonary infiltrates in immunocompromised patients require an expanded infectious and noninfectious differential.

The immune defect affects both susceptibility and the intensity of tissue inflammation.

Morphology and distribution help prioritize organisms but do not replace confirmatory evidence.

Multiple causes are possible; Reconcile each finding with the complete clinical context.

Slide 74 · Source references

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition. Chapter 15: The Lung — Pulmonary Infections.

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition. Chapter 8: Infectious Diseases — organism-specific pathology.

Privacy preferences

Essential storage remembers your theme and privacy choice. Secure forms and teaching requests remain available whichever option you choose.

Teaching activity uses separate aggregate counters and short-lived sessions. SlideShare links open the original presentations on SlideShare. Form security checks are provided by third parties.

No message text, email addresses, visitor identifiers, or destination URLs are included in optional measurement. Read privacy details